Processa Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $12,469 | $0 |
Gross Profit | 6,234 | -3,424 | ||
EBITDA | -3,933 | -2,846 | -2,734 | -3,424 |
EBIT | -3,933 | -2,846 | -2,734 | -3,424 |
Net Income | -3,933 | -2,834 | -2,728 | -3,384 |
Net Change In Cash | 0 | 0 | 12,469 | 0 |
Free Cash Flow | -2,270 | -2,729 | -2,247 | -3,605 |
Cash | 6,936 | 2,897 | 1,191 | 2,891 |
Basic Shares | 15 | 9 | 3,509 | 3,275 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -874 | -875 | ||
EBITDA | -11,849 | -11,456 | -19,469 | -11,082 |
EBIT | -11,850 | -11,457 | -20,343 | -11,957 |
Net Income | -11,850 | -11,121 | -27,424 | -11,427 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,248 | -8,066 | -9,605 | -8,717 |
Cash | 1,191 | 4,706 | 6,503 | 16,497 |
Basic Shares | 3,059 | 1,311 | 16,109 | 765 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.25 |
2025-03-31 | -$0.30 |
2024-12-31 | -$0.74 |
2024-09-30 | -$1.03 |
